Wordt geladen...
GSK3 is required for rapalogs to induce degradation of some oncogenic proteins and to suppress cancer cell growth
The single-agent activity of rapalogs (rapamycin and its analogues) in most tumor types has been modest at best. The underlying mechanisms are largely unclear. In this report, we have uncovered a critical role of GSK3 in regulating degradation of some oncogenic proteins induced by rapalogs and cell...
Bewaard in:
| Gepubliceerd in: | Oncotarget |
|---|---|
| Hoofdauteurs: | , , , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Impact Journals LLC
2015
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4496196/ https://ncbi.nlm.nih.gov/pubmed/25797247 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|